NT PHARMA(01011.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
NT PHARMA
01011.HK
China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge.
1.226 T
01011.HKMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking46/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE7.74%B
    • Profit Margin-107.79%E
    • Gross Margin39.78%B
  • Growth ScoreD
    • Revenue YoY-35.74%E
    • Net Profit YoY50.72%B
    • Total Assets YoY8.68%B
    • Net Assets YoY28.28%A
  • Cash ScoreE
    • Cash Flow Margin0.00%D
    • OCF YoY-35.74%E
  • Operating ScoreE
    • Turnover0.07E
  • Debt ScoreE
    • Gearing Ratio178.84%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    China NT Pharma Discloses Governance Dispute Behind Director’s Resignation

    Tip Ranks·
    HK
    01011
    0.00%
    SH
    513700
    +1.42%
    SH
    512290
    +2.02%
    Tip Ranks·
    HK
    01011
    0.00%
    SH
    513700
    +1.42%
    SH
    512290
    +2.02%

    China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen

    Tip Ranks·
    HK
    01011
    0.00%
    Tip Ranks·
    HK
    01011
    0.00%

    China NT Pharma details board and committee structure

    Tip Ranks·
    HK
    01011
    0.00%
    Tip Ranks·
    HK
    01011
    0.00%

    China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate

    Tip Ranks·
    HK
    01011
    0.00%
    Tip Ranks·
    HK
    01011
    0.00%

    "Performance" NT PHARMA's annual loss narrowed to 26.041 million RMB, no dividend distribution

    AASTOCKS·
    SZ
    159837
    +1.73%
    SH
    510660
    +2.35%
    SH
    588130
    +3.07%
    AASTOCKS·
    SZ
    159837
    +1.73%
    SH
    510660
    +2.35%
    SH
    588130
    +3.07%
    © 2026 Longbridge｜Disclaimer